Organization
Fredrik Rickman (previously Persson)
CEO since 2017
About:
B.Sc in Business Administration and Economics, University of Lund. 30+ years of international life science industry experience in leading positions with focus on operational and organizational growth.
Other assignments:
Stradis Med Nordics AB; Chairman of the Board
Holdings in the Company:
See Insiders information
Steve Gaal
President US operations since 2023
Holdings in the Company:
See Insiders information
About:
BA in Business Administration, East Stroudsburg University. Steven brings over 19 years of successful commercial experience in molecular diagnostics and oncology. Previously, he served as Commercial Director-US of Skyline Diagnostics, a Dutch-owned San Diego based-CAP/CLIA genomics laboratory providing LDT assays for melanoma and multiple myeloma prognosis. At MDxHealth he was instrumental in the launch and clinical adoption of the company’s tissue and urine-based LDT tests in urology and oncology. He has also held leadership roles at P4 Diagnostics, was National Director of Sales/Hospital Pathology at LabCorp/US LABS (acquired by LabCorp).
Other assignments:
–
Holdings in the Company:
See Insiders information
Anders Koch
CFO since 2023
About:
M.Sc. in Economics and Business, Stockholm University. Deep experience in financial reporting and managerial finance cemented from 13 years as authorized public accountant with PwC followed by 13+ years as CFO, Financial Controller and member of the Executive Management teams in the Telecom and Digital Media Production industries.
The position is part-time.
Other assignments:
Carisus Consulting AB; Founder and owner
Holdings in the Company:
See Insiders information
Emelie Berglund
CTO since 2022
About:
P.hD. in Biotechnology from KTH (Royal Institute of Technology) in Stockholm.
Emelie has 10 years of experience working in research within the prostate cancer field and 5 years of private sector experience from working in diagnostic product development.
Other assignments:
–
Holdings in the Company:
See Insiders information
Dr. Gerald Andriole
CMO since 2022
About:
MD from Thomas Jefferson University in Philadelphia.
35+ years in academic and clinical medicine as director of Urology at Washington University and Johns Hopkins University; led the USA’s largest randomized prostate cancer screening trial (NIH PLCO trial) and the international REDUCE prostate cancer chemoprevention trial; over 450 peer-reviewed scientific publications.
Other assignments:
–
Holdings in the Company:
See Insiders information
Katarina Sjöberg
Head of RA and QA EMEA since 2023
About:
30+ years of experience of IVD products (reagents and software) in quality management, leadership and the regulatory landscape. Katarina has had different roles within QA/RA, R&D and operations. Responsibilities have included different regulations and standards related to e.g US, Europe, China, Japan.
Other assignments:
–
Holdings in the Company:
See Insiders information